Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Teladoc Health (NYSE:TDOC – Get Rating) was upgraded by equities researchers at StockNews.com to a “sell” rating in a research note issued to investors on Tuesday.
A number of other equities research analysts have also recently issued reports on TDOC. Royal Bank of Canada decreased their target price on Teladoc Health from $53.00 to $35.00 in a research report on Wednesday, September 28th. DA Davidson dropped their price target on Teladoc Health from $45.00 to $40.00 and set a “buy” rating on the stock in a research report on Tuesday, October 25th. KeyCorp started coverage on Teladoc Health in a research report on Thursday, September 15th. They issued a “sector weight” rating for the company. Barclays dropped their target price on shares of Teladoc Health from $33.00 to $32.00 and set an “equal weight” rating on the stock in a research report on Thursday, October 27th. Finally, Cowen decreased their target price on Teladoc Health to $30.00 in a research report on Thursday, October 27th. One research analyst has rated the stock with a sell rating, twenty-two have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $48.21.
Teladoc Health Stock Down 3.0 %
Shares of TDOC traded down $0.70 during midday trading on Tuesday, reaching $22.83. 4,995,800 shares of the stock were exchanged, compared to its average volume of 5,620,191. The company has a market cap of $3.70 billion, a price-to-earnings ratio of -0.37 and a beta of 0.94. The company has a quick ratio of 2.99, a current ratio of 3.13 and a debt-to-equity ratio of 0.25. Teladoc Health has a 12-month low of $22.76 and a 12-month high of $96.64. The firm has a 50 day simple moving average of $27.50 and a 200-day simple moving average of $31.32.
Teladoc Health (NYSE:TDOC – Get Rating) last released its quarterly earnings data on Wednesday, October 26th. The health services provider reported ($0.45) EPS for the quarter, topping analysts’ consensus estimates of ($0.59) by $0.14. The firm had revenue of $611.40 million for the quarter, compared to the consensus estimate of $609.45 million. Teladoc Health had a negative return on equity of 2.47% and a negative net margin of 424.40%. Research analysts forecast that Teladoc Health will post -1.4 EPS for the current year.
Insider Activity at Teladoc Health
In other news, insider Arnnon Geshuri sold 2,398 shares of Teladoc Health stock in a transaction dated Monday, November 28th. The stock was sold at an average price of $27.35, for a total value of $65,585.30. Following the transaction, the insider now owns 74,317 shares in the company, valued at $2,032,569.95. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In the last 90 days, insiders have sold 3,925 shares of company stock valued at $105,198. Insiders own 1.55% of the company’s stock.
Hedge Funds Weigh In On Teladoc Health
Several hedge funds and other institutional investors have recently modified their holdings of TDOC. Teachers Retirement System of The State of Kentucky bought a new stake in Teladoc Health during the third quarter worth about $756,000. Captrust Financial Advisors increased its position in Teladoc Health by 200.9% during the 3rd quarter. Captrust Financial Advisors now owns 20,301 shares of the health services provider’s stock valued at $515,000 after buying an additional 13,555 shares in the last quarter. Hershey Trust Co. lifted its stake in shares of Teladoc Health by 3.7% in the third quarter. Hershey Trust Co. now owns 65,550 shares of the health services provider’s stock worth $1,662,000 after buying an additional 2,323 shares in the last quarter. Oliver Lagore Vanvalin Investment Group raised its holdings in Teladoc Health by 94.3% in the 3rd quarter. Oliver Lagore Vanvalin Investment Group now owns 1,030 shares of the health services provider’s stock worth $26,000 after acquiring an additional 500 shares during the last quarter. Finally, Public Employees Retirement System of Ohio lifted its position in Teladoc Health by 1.5% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 85,847 shares of the health services provider’s stock valued at $2,176,000 after acquiring an additional 1,308 shares in the last quarter. Hedge funds and other institutional investors own 84.14% of the company’s stock.
Teladoc Health Company Profile
(Get Rating)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
Featured Stories
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- The Institutions Choose CarMax Over Carvana, Should You?
- Heatmap in Trading: How to Learn What Market Depth Hides
- Micron Technology Sees Chip Recovery by the End of 2023
- Three Healthcare Penny Stocks to Watch In The New Year
- Southwest Airlines Stock, There is a Lot to Love
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teladoc Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Teladoc Health wasn’t on the list.
While Teladoc Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by entering your email address below.
Enter your email address below and we’ll send you MarketBeat’s guide to investing in 5G and which 5G stocks show the most promise.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
